Retrospective analysis of nanoparticle albumin-encapsulated paclitaxel versus dacarbazine in advanced melanoma

被引：0
|
作者：
Chalasani, P. [1 ]
Morgan, S. S. [1 ]
Butcher, D. [1 ]
Jeter, J. M. [1 ]
Hersh, E. [1 ]
Cranmer, L. D. [1 ]
机构：
[1] Univ Arizona, Arizona Canc Ctr, Tucson, AZ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e19002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19002
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A peptide- modified solid lipid nanoparticle formulation of paclitaxel modulates immunity and outperforms dacarbazine in a murine melanoma model
    Banerjee, Indranil
    De, Manjarika
    Dey, Goutam
    Bharti, Rashmi
    Chattopadhyay, Sankha
    Ali, Nahid
    Chakrabarti, Partha
    Reis, Rui L.
    Kundu, Subhas C.
    Mandal, Mahitosh
    BIOMATERIALS SCIENCE, 2019, 7 (03) : 1161 - 1178
  • [22] An Analysis of Peripheral Neuropathy in a Phase III Trial of nab-Paclitaxel versus Dacarbazine in Chemotherapy-Naive Patients with Metastatic Melanoma
    Del Vecchio, M.
    Hersh, E.
    Brown, M. P.
    Clements, A.
    Loquai, C.
    Ferruci, P. F.
    Robert, C.
    Li, M.
    Elias, I
    Renschler, M. F.
    Hauschild, A.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 56 - 56
  • [23] Nanoparticle albumin-bound paclitaxel in elder patients with advanced squamous non-small-cell lung cancer: A retrospective study
    Liu, Yang
    Dong, Yinping
    Zhu, Hui
    Jing, Wang
    Guo, Hongbo
    Yu, Jinming
    CANCER MEDICINE, 2020, 9 (04): : 1365 - 1373
  • [24] Meta-Analysis of the Safety and Efficacy of Interferon Combined With Dacarbazine Versus Dacarbazine Alone in Cutaneous Malignant Melanoma
    Xin, Yong
    Huang, Qian
    Zhang, Pei
    Yang, Ming
    Hou, Xiao-Yang
    Tang, Jian-Qin
    Zhang, Long Zhen
    Jiang, Guan
    MEDICINE, 2016, 95 (16)
  • [25] Nanoparticle albumin-bound paclitaxel versus solvent-based paclitaxel in breast cancer A protocol for systemic review and meta-analysis
    Li, Bingxue
    Chen, Xinjie
    Ding, Tongjing
    Liu, Yihua
    Ma, Tingting
    Zhang, Ganlin
    Wang, Xiaomin
    MEDICINE, 2021, 100 (07) : E24514
  • [26] Weekly nanoparticle albumin-bound paclitaxel and paclitaxel for relapsed small cell lung cancer A retrospective observational study
    Oi, Hajime
    Matsuda, Toshiaki
    Kimura, Tomoki
    Morise, Masahiro
    Yamano, Yasuhiko
    Yokoyama, Toshiki
    Kataoka, Kensuke
    Kondoh, Yasuhiro
    MEDICINE, 2022, 101 (06) : E28863
  • [27] Retrospective comparisons of nanoparticle albumin-bound paclitaxel and docetaxel neoadjuvant regimens for breast cancer
    Li, Yan
    Chen, Xiang
    Zhu, Qiannan
    Chen, Rui
    Xu, Lu
    Li, Shuo
    Shi, Xiaoqing
    Xu, Haiping
    Xu, Yinggang
    Zhang, Weiwei
    Huang, Xiaofeng
    Zha, Xiaoming
    Wang, Jue
    NANOMEDICINE, 2021, 16 (05) : 391 - 400
  • [28] ECONOMIC EVALUATION OF NANOPARTICLE ALBUMIN-BOUND PACLITAXEL FOR PREVIOUSLY TREATED ADVANCED NSCLC IN JAPAN
    Fukui, Y.
    Chen, W.
    Maeda, T.
    Morimoto, K.
    Moriwaki, K.
    Shimozuma, K.
    VALUE IN HEALTH, 2023, 26 (06) : S150 - S150
  • [29] Randomized trial of dacarbazine versus bleomycin, vincristine, lomustine and dacarbazine (BOLD) chemotherapy combined with natural or recombinant interferon-α in patients with advanced melanoma
    Vuoristo, MS
    Hahka-Kemppinen, M
    Parvinen, LM
    Pyrhönen, S
    Seppä, H
    Korpela, M
    Kellokumpu-Lehtinen, P
    MELANOMA RESEARCH, 2005, 15 (04) : 291 - 296
  • [30] Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma
    Middleton, MR
    Grob, JJ
    Aaronson, N
    Fierlbeck, G
    Tilgen, W
    Seiter, S
    Gore, M
    Aamdal, S
    Cebon, J
    Coates, A
    Dreno, B
    Henz, M
    Schadendorf, D
    Kapp, A
    Weiss, J
    Fraass, U
    Statkevich, P
    Muller, M
    Thatcher, N
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (01) : 158 - 166
12345